Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Opened with a surge of nearly three times and multiple trading halts, the SpaceX and OpenAI-backed fund PWRL soared 131% on its first day.

Opened with a surge of nearly three times and multiple trading halts, the SpaceX and OpenAI-backed fund PWRL soared 131% on its first day.

BlockBeatsBlockBeats2026/05/28 04:19
Show original

According to monitoring by 动察 Beating, the closed-end fund Powerlaw Corp. (stock code: PWRL), which bundles SpaceX and OpenAI equities, was listed on Nasdaq on May 27 local time. On its first day, trading immediately triggered multiple intraday volatility circuit breakers, ultimately closing up 131.44% at $27.68. On the first trading day, the fund opened at $35.00, soaring nearly three times higher than the exchange’s reference price of $11.96. During the session it spiked to a peak of $40.00, with after-hours trading continuing up to $28.99.

The surge in share price directly led to an extremely high capital premium for the fund's trading price. Based on net assets of $604.1 million reported on May 13, Powerlaw’s actual net asset value (NAV) per share is only $13.97. This means the closing price of $27.68 already represents a 98.14% premium over the real asset value, effectively meaning retail investors are paying nearly double on the public market for tech company equities that have not gone public. When the intraday high reached $40.00, the asset premium rate was even pushed up to 186.33%.

The trading volume on the first day reached 1.1013 million shares, with total daily turnover of $37.149 million, and the fund's total market value surged to $1.197 billion at the close. The extreme price divergence reflects a sense of FOMO (fear of missing out) among the market towards equity holdings in top unicorns such as SpaceX (share value about $117 million), OpenAI (share value about $46.9 million), as well as Anthropic and xAI. However, since nearly 80% of the fund’s assets are indirectly held through special purpose vehicles (SPVs) and are currently subject to compliance scrutiny from Anthropic and other companies over SPV violations, the multiple layers of hidden costs and potential proxy holding exit risks may put pressure on the premium share price in subsequent trading.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11